Search results for: 'biologics 2024'
- Did you mean
- biologics 2014
- Related search terms
- 2024 Frost & Sullivan TechnoGlobal Autonomous Clogy Innovation Leadership Award - The Global Vision Processing Unit Industry
- 2024 china servic operations system industry market research report
- biologics contract development ar manufacturing market forecast to 2024
- biologics contract development ar manufacturing market forecast to 2014
- biologics contract development ar manufacturing market forecast to 2025
-
20 Nov 2017  |  North America  |  Market Research
Global Biologics Market—Companies-to-Action
Biopharma Companies are Increasingly Collaborating with CDMOs, CROs, and Digital and Medical Equipment Companies for Biologics Discovery and Development
This study on the "Global Biologics Market: Companies-to-Action" presents an overview of the global biologics landscape with an emphasis on the top 10 leading bio-pharma companies in the market. The study highlights the shifting focus and investments of bio-pharma companies towards biologics discovery and development, which is attributed to the gro...
$3,000.00
Special Price $2,250.00 save 25 %
-
19 Sep 2018  |  North America  |  Market Research
Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022
Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics
The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global b...
$4,950.00
Special Price $3,712.50 save 25 %
-
24 Jul 2020  |  North America  |  Market Research
Curative Oncology and Rare Disease Therapies Transforming the Global Biologics Market, 2020–2024
Strategic Collaborations with Specialty Bio-CDMOs will Continue to Drive Growth Opportunities in Antibody-drug Conjugates and Gene Therapies
With this research service, Frost & Sullivans Transformational Health team provides critical insights into the global biologics industry highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The global biologics market covered in this study includes 4 major segments – antibody therapies, r...
$4,950.00
Special Price $3,712.50 save 25 %
-
24 Dec 2024  |  North America  |  Tracker
Apple Performance Tracker, Q1 2024
Smartphones, Services, and Wearables Generated the Best Growth Opportunities in 2024
This Frost & Sullivan tracker provides metrics on Apple's quarterly performance (for both unit sales and revenues) for iPads, iPhones, Macs, and other products, such as iPods, Apple TVs, Beats Electronics, and Apple-branded and third-party accessories. This tracker includes historical quarterly data for these categories from Q1 2007 to Q4 2023 and ...
$1,500.00
Special Price $1,275.00 save 15 %
-
20 Dec 2024  |  North America  |  Tracker
Apple Performance Tracker, Q2 2024
Smartphone, Services, and Wearables Generated the Best Growth Opportunities in 2024
This Frost & Sullivan tracker provides metrics on Apple's quarterly performance (for both unit sales and revenues) for iPads, iPhones, Macs, and other products, such as iPods, Apple TVs, Beats Electronics, and Apple-branded and third-party accessories. This tracker includes historical quarterly data for these categories from Q1 2007 to Q4 2023 and ...
$1,500.00
Special Price $1,275.00 save 15 %
-
26 Aug 2024  |  North America  |  Tracker
North American Mobile Tracker, Q2 2024
5G Mobile Computing, Fixed Wireless Access, Wearables, and IoT Devices to Ensure Future Growth Potential of North American Mobile Operators
The continued penetration of high-speed broadband services into advanced mobile devices, developments in the cellular machine-to-machine (M2M) and Internet of Things (IoT) markets, and the resurgence of unlimited mobile plans are the top drivers of the North American mobile communications market. This tracker presents metrics for leading mobile ope...
$4,950.00
Special Price $4,207.50 save 15 %
-
15 Feb 2022  |  North America  |  Market Research
Global Biologics Contract Development and Manufacturing Organization Profiles and Growth Opportunities
The Contract Research, Development, and Manufacturing Organization Business Model to Drive Future Growth Potential
Frost & Sullivan provides comprehensive insights into the global biologics contract development and manufacturing organization (bio-CDMO) market, including emerging trends, growth opportunities, and profiles of leading bio-CDMOs and their business model evolution. The growth of next-generation biologics and personalized therapies and the emergence ...
$2,450.00
Special Price $1,837.50 save 25 %
-
17 Jun 2021  |  North America  |  Market Research
Global Biologics Contract Development and Manufacturing Organizations Growth Opportunities
Asset Co-Development with Clinical-stage Biopharmaceutical Companies and Disruptive Technologies Present Future Growth Potential
This study presents Frost & Sullivans overall market and segment-wise revenue forecasts of the global biologics contract development and manufacturing organizations (bio-CDMO) market. It also highlights key growth opportunities for bio-CDMO market participants based on the main evolution in their business models and strategic approaches, as well as...
$4,950.00
Special Price $3,712.50 save 25 %
-
02 May 2011  |  North America  |  Market Research
U.S. Rheumatoid Arthritis Market: Assessment of Biologics and New Treatments
This research service covers the U.S. rheumatoid arthritis (RA) market from 2007 to 2017, with 2010 as the base year. Included in this research service are products currently in the market, products in development, and patient forecasts. Market challenges, drivers, and restraints are identified and assessed. Strategic recommendations are presented ...
$4,950.00
Special Price $3,712.50 save 25 %
-
08 Jun 2022  |  North America  |  Market Research
Growth Opportunities in Sterile Injectable Outsourcing
Biologics Drive the Future Growth Potential of Sterile Injectable Outsourcing
Injectables constitute one of the fastest growing segments in the pharmaceuticals space. Many drugs, including biologics, are going off patent in next 3 or 4 years, which will lead to an increase in the demand for generics and biosimilar injectables. The increase in onshoring and nearshoring of biopharmaceutical products for COVID-19 and next-gen...
$2,450.00
Special Price $1,837.50 save 25 %